Benchmark raises Intel stock price target on manufacturing progress By Investing.com

Benchmark raised Intel's price target to $140 from $105 while maintaining a Buy rating, citing improved visibility on the turnaround and stronger earnings potential in fiscal 2027-2028. Management said 18A yields are running 2-3 months ahead of internal benchmarks, with server CPU supply expected to stay tight through 2026 and possibly into 2027. The article also notes 30 analysts have recently revised earnings estimates higher, with Intel expected to return to profitability this year at $1.12 per share.

Analysis

The market is still pricing Intel like a turnaround optionality story, but the more interesting setup is a near-term supply squeeze with multi-quarter duration. If server CPU availability is the binding constraint rather than demand, then the earnings inflection can persist even in a mixed macro tape, because customers forced to allocate capacity tend to preserve pricing and mix before they chase share. That creates a second-order beneficiary set: downstream OEMs and cloud infrastructure buyers may face procurement delays, while foundry/tooling and advanced packaging vendors can capture incremental wallet share from every incremental wafer and assembly step Intel externalizes.

The key contrarian point is that improved visibility can coexist with limited near-term upside in the stock if the narrative is already front-running 2027-2028 earnings power. Intel’s rerating is likely to be more path-dependent than estimate-dependent: the equity can continue to work on evidence of supply ramp and yield progress, but any slip in 18A execution or a moderation in server tightness would compress the multiple quickly because the market is paying for proof, not promises. The biggest risk is not demand destruction; it is that capacity relief arrives just as expectations peak, which would convert a scarcity premium into a normalization trade.

Compared with the headline optimism, the cleaner expression may be relative rather than outright long. The situation favors pairing Intel exposure against names leveraged to a faster AI demand cycle if one believes general-purpose CPU growth is durable but not explosive. Another underappreciated angle is that improved Intel execution can be mildly negative for merchant semiconductor peers over time because a stronger domestic CPU/foundry stack reduces the scarcity premium those names have enjoyed.

From a timing standpoint, the next 4-8 weeks are about catalyst validation rather than fundamental re-rating; the next 12-24 months are about whether supply constraints translate into sustainable operating leverage. If management cadence stays constructive into the next two quarters, the stock can grind higher, but the asymmetry worsens once consensus fully updates to the recovery path.

Key Decisions for Investors

• Maintain a tactical long INTC position into the next 1-2 quarters, but size it as a catalyst trade rather than a core compounder; upside is driven by proof of execution, not terminal value, and downside is sharp if yield/supply commentary softens.
• Sell upside calls against existing INTC longs into strength over the next earnings window; implied volatility should stay elevated, and the stock may already be discounting the next leg of estimate revisions.
• Pair trade: long INTC / short a basket of high-multiple semiconductor names most exposed to normalization in supply-chain scarcity premiums, with a 3-6 month horizon and a stop if Intel execution slips.
• For event-driven traders, consider a defined-risk call spread in INTC targeting the next two earnings reports; reward/risk is favorable if management reiterates tight supply and yield beats persist, but downside is capped if the ramp is merely in line.
• Watch for any sign that server CPU tightness extends into 2027; if confirmed, add on pullbacks because that would extend pricing power and delay competitive share loss for at least 4-6 quarters.